Skip to Main Content

Author Details

Nicholas Brian Shannon
Singapore General Hospital
2010
34
13
PMIDPaper TitleJournal TitlePublished Year
37163461Impact of COVID-19 on Public Interest in Breast Cancer Screening and Related Symptoms: Google Trends Analysis.JMIR Cancer2023
35759206Adherence to Multidisciplinary Tumor Board Recommendations in Patients With Curable Esophageal and Gastric Cancers.J Gastrointest Cancer2023
37035307Improving the accuracy of revised cardiac risk index with HbA1C: Hemoglobin ratio (HH ratio) - A retrospective cohort study.Front Med (Lausanne)2023
35243423Ligand-mediated PAI-1 inhibition in a mouse model of peritoneal carcinomatosis.Cell Rep Med2022
35875164Risk Stratification in Oral Cancer: A Novel Approach.Front Oncol2022
33181310A Newly Proposed HbA1C-Hemoglobin Ratio - A Better Predictor of Outcomes in Cardiac Surgery When Compared to HbA1C and Anemia Alone.Semin Thorac Cardiovasc Surg2021
34413360A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer.Sci Rep2021
34207401Gene Expression Changes Associated with Dedifferentiation in Liposarcoma Predict Overall Survival.Cancers (Basel)2021
33091845Pairing a prognostic target with potential therapeutic strategy for head and neck cancer.Oral Oncol2020
31959771An Optimised Protocol Harnessing Laser Capture Microdissection for Transcriptomic Analysis on Matched Primary and Metastatic Colorectal Tumours.Sci Rep2020
32095247Spontaneous spinal epidural haematoma following intra-arterial catheter-directed thrombolysis: A case report.SAGE Open Med Case Rep2020
31332257A set of molecular markers predicts chemosensitivity to Mitomycin-C following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis.Sci Rep2019
31391066P.R.O.P.S. - A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).World J Surg Oncol2019
28683587CA-125: an inaccurate surveillance tool immediately after cytoreductive surgery and hyperthermic intraoperative chemotherapy (CRS-HIPEC)?Int J Hyperthermia2018
29938571Reply to letter: Nephrotoxic synergism of cisplatin and mitomycin-C for hyperthermic intraperitoneal chemotherapy and cytoreductive surgery by Kapoor R, Robinson K and Badgwell B.Int J Hyperthermia2018
29988907The impact of urological resection and reconstruction on patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).Asian J Urol2018
29772933The Approach to Solitary Fibrous Tumors: Are Clinicopathological Features and Nomograms Accurate in the Prediction of Prognosis?Int J Surg Pathol2018
29255247GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.Oncogene2018
28689443Does having a gastrectomy delay time to feeding and prolong hospital stay in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?Int J Hyperthermia2018
28633580Platinum agents and mitomycin C-specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).Int J Hyperthermia2018
29066646Recurrence of immature ovarian teratoma as malignant follicular carcinoma with liver and peritoneal metastasis 22 years after completion of initial treatment.BMJ Case Rep2017
28465312A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.Genome Res2017
29108335A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancer.Oncotarget2017
28974564Corrigendum: A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.Genome Res2017
25263463Selective insulin resistance in hepatocyte senescence.Exp Cell Res2015
24952744Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.Nat Genet2014
25240687The senescent hepatocyte gene signature in chronic liver disease.Exp Gerontol2014
24777112Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.J Natl Cancer Inst2014
22773546A systematic approach to therapeutic target selection in oesophago-gastric cancer.Gut2013
23900255Computational approaches to identify functional genetic variants in cancer genomes.Nat Methods2013
23509313Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.J Clin Oncol2013
23243219DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.Clin Cancer Res2013
20080664Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers.Proc Natl Acad Sci U S A2010
20584750Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinoma.Carcinogenesis2010
  • 1 - 34 of 34

Recommended Authors

Institut de Pathologie Multisite
Career Start Year 2013
Number of shared co-authors 1
Crown Princess Mary Cancer Centre, Westmead Hospital
Career Start Year 2008
Number of shared co-authors 1
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
Oslo University Hospital
Career Start Year 2007
Number of shared co-authors 0
University of California
Career Start Year 2007
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Tisch Cancer Institute, Mount Sinai Hospital
Career Start Year 2005
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Cancer Center Amsterdam
Career Start Year 2001
Number of shared co-authors 1
HM Hospitales-Centro Integral Oncologico Clara Campal
Career Start Year 2001
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 1
University of British Columbia
Career Start Year 2000
Number of shared co-authors 3
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
National Defense Medical College
Career Start Year 1993
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 3
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 3
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 2
University of California San Diego
Career Start Year 1985
Number of shared co-authors 0

Collaborators

Irving Institute for Cancer Dynamics, Columbia University
Co-authored papers 3
University of St Andrews
Co-authored papers 3
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 3
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 2
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 2
University of California San Diego
Co-authored papers 1
Universitat Pompeu Fabra
Co-authored papers 1
Kurume University School of Medicine
Co-authored papers 1
Humboldt-Universitat zu Berlin
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
University of Helsinki
Co-authored papers 1
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 1
The Medical School, The University of Sheffield
Co-authored papers 1
Wellcome Sanger Institute
Co-authored papers 1
University of Cambridge
Co-authored papers 1
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 1
Co-authored papers 1
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Co-authored papers 1
Universitat Pompeu Fabra
Co-authored papers 1
Josep Carreras Leukaemia Research Institute (IJC)
Co-authored papers 1
University of California at Santa Cruz
Co-authored papers 1
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Norwegian University of Science and Technology
Co-authored papers 1
Wellcome Sanger Institute
Co-authored papers 1
University of Toronto
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Johns Hopkins University
Co-authored papers 1
NIHR Oxford Biomedical Research Centre
Co-authored papers 1
Harvard Medical School
Co-authored papers 1